NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

作者：Emmanuelle Clappier, Sandra Collette, Nathalie Grardel, Stéphane Girard, Lydia Suarez, Ghislaine Brunie, Sophie Kaltenbach, Karima Yakouben, Françoise Mazingue, A.V. Michaud Robert, Patrick Boutard, Dominique Plantaz, Pierre‐Simon Rohrlich, Pieter Van Vlierberghe, Claude Preudhomme, Jacques Otten, Frank Speleman, Nicole Dastugue, Stefan Suciu, Yves Benoît, Y Bertrand, Hélène Cavé, on behalf of the EORTC-CLG · 发表于：Leukemia · 年份：2010 · DOI：10.1038/leu.2010.205 · 被引用次数：129 · 研究领域：Acute Lymphoblastic Leukemia research、Acute Myeloid Leukemia Research、Chronic Myeloid Leukemia Treatments